Reimagining Vaccine Development with AI
The increasing urgency and frequency of emerging infectious diseases necessitates faster, more agile and scalable vaccine solutions.1 While the rapid spread of health threats is…
AI Pharma
As New Rules Take Hold, what does ‘Good AI Practice’ look like in Drug Development?
In 2026, setting clear AI expectations is the priority. On January 14, 2026, EMA and FDA marked a step towards regulatory alignment by publishing joint…
Regulation is Pushing European Medtech to Streamline Clinical Trial Operations
As the medtech industry evolves, companies are facing resource limitations, the burden of manual processes, greater clinical evidence demands, and site collaboration challenges. For medtechs…
Revolutionizing Data Capture through Integrated Patient Experience Platforms
Clinical trials are fundamentally changing the way patient experience data is captured. In a time when regulators are putting much greater emphasis on patient-focused drug…
Taming the AI Chaos in Drug Discovery
Key Points AI chaos is a success-driven challenge: Powerful, specialized AI tools are proliferating faster than labs can integrate them coherently. Fragmentation creates hidden costs:…
From Support to Strategy: Will 2026 be the Year of the AI-augmented Medical Affairs Team?
Over the past several years, Medical Affairs has evolved from a largely supportive, reactive function into a primary strategic pillar. In 2026, proving the value…
Are Pharma’s Data Transformation Efforts Targeting the Right Challenge?
For more than a decade life sciences organisations have spoken confidently about becoming data-driven; more recently about becoming AI-powered. Yet compared with other highly-regulated sectors,…
Bridging the Diagnostics Gap – How to Finance Smarter Labs
The UK’s National Health Service (NHS) is increasingly struggling to meet its diagnostic targets. As of August 2025, over 1.6 million people were on waiting…
Agentic AI: How can Pharma Harness its Coordinated Reasoning?
With agentic AI, the promise is about so much more than process enhancement and greater productivity. It is about redefining a function’s purpose and value,…
Lessons in AI Use – What Worked for Boehringer Ingelheim in a PV Context?
Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, chart Boehringer’s shift to AI-powered automation of…